In The Press December 23, 2020

Will These Big Biosimilar Questions Be Answered In 2021? (Biosimilar Development)

Biosimilar Development asks Goodwin Intellectual Property Litigation partner Alexandra Valenti what her biggest questions are going into 2021 and if there any solutions in the works (i.e., government policies, stakeholder partnerships, market launches, internal developments at your company/organization) that could address these questions. Read the article here.